Transcription of OCREVUS Prescribing Information - Genentech
{{id}} {{{paragraph}}}
Example: air traffic controller
OCREVUS Prescribing Information - Genentech
HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use OCREVUS safely and effectively. See full Prescribing Information for (ocrelizumab) injection, for intravenous useInitial Approval: 2017---------------------------RECENT MAJOR CHANGES---------------------------Dosage and Administration ( , ) 12/2020 Warnings and Precautions( , )11/2020---------------------------INDIC ATIONS AND USAGE---------------------------- OCREVUS is aCD20-directed cytolytic antibody indicated for the treatment of.
1Solutions of OCREVUS for intravenous infusion are prepared by dilution of the drug product into an infusion bag containing 0.9% Sodium ChlorideInjection, to a final drug concentration ofapproximately 1.2 mg/mL. 2Administer the first Subsequent Dose6 months after Infusion 1 …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: